In this module we delve into prophylactic treatment of patients with Von Willebrand Disease. The content will be primarily presented by Prof. Dr. Miesbach (internist-hematologist at the University Hospital Frankfurt am Main), who will provide an overview of the pros and cons of prophylactic treatment and the latest developments in this indication, including key highlights from pivotal clinical trials. Dr. Miesbach will also address which type of VWD patients may be best suited for prophylactic treatment, supported by case studies.